+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

  • ID: 2786167
  • Report
  • Region: Global
  • 121 Pages
  • GBI Research
1 of 5
Global Insulin Delivery Devices Market to see Significant Growth during the Forecast Period

FEATURED COMPANIES

  • Abbott Laboratories
  • Antares Pharma
  • Eli Lilly
  • Injex - Equidyne Systems
  • Medtronic
  • Sanofi
  • MORE
This report examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope:

- The markets of 12 key geographies are covered: US, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Annual market revenue data forecast to 2019 and company share data for 2012.
- Qualitative analysis of key trends in the insulin delivery devices market.
- Information on the competitive landscape and the leading technologies of key players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly, Becton, Dickinson and Company, Animas, Insulet, F. Hoffmann-La Roche, Abbott Laboratories.
- Information on reimbursement trends and market access for key countries.

Reasons to Purchase:

- Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market.
- Design and enhance your product development, marketing, and sales strategies.
- Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines.
- Develop market-entry and market-expansion strategies.
- Identify the key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
- Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape.
- Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Antares Pharma
  • Eli Lilly
  • Injex - Equidyne Systems
  • Medtronic
  • Sanofi
  • MORE
1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

3 Diabetes – Disease Overview

3.1 Types of Diabetes
3.1.1 Type 1 Diabetes
3.1.2 Type 2 Diabetes
3.1.3 Gestational Diabetes
3.1.4 Signs and Symptoms
3.1.5 Diabetes Diagnosis
4 Diabetes – Epidemiology

5 Global Insulin Delivery Devices Market: Device Overview

5.1 Insulin Pen
5.1.1 Reusable Pen
5.1.2 Disposable Pen
5.1.3 Pen Needle
5.2 Insulin Pump
5.2.1 Traditional Insulin Pump
5.2.2 Disposable Insulin Pump
5.3 Insulin Syringe
5.4 Traditional Insulin Pump Accessories
5.5 Comparison of Insulin Delivery Devices

6 Global Insulin Delivery Devices Market: Market Characterization

6.1 Global Insulin Delivery Devices Market, Revenue ($bn), 2005–2012
6.2 Global Insulin Delivery Devices Market, Revenue, 2012–2019
6.3 Insulin Delivery Devices Market, Global, Key Company Shares, 2012
6.3.1 Global
6.3.2 North America
6.3.3 Europe
6.3.4 Asia-Pacific
6.4 Insulin Delivery Devices Market, Key Trends
6.4.1 Companies Move Closer to Developing Fully Automated Artificial Pancreas System
6.4.2 Collaborations Foster Innovation in Insulin Delivery Devices Market
6.4.3 Inhaled Rapid-Acting Insulin Studied in Research of Artificial Pancreas System
6.5 Market Dynamics
6.5.1 Market Drivers
6.5.2 Market Restraints

7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts

7.1 Insulin Pens Market, Global, Revenue, 2005–2012
7.2 Insulin Pens Market, Global, Revenue, 2012–2019
7.3 Insulin Pumps Market, Global, Revenue, 2005–2012
7.4 Insulin Pumps Market, Global, Revenue, 2012–2019
7.5 Insulin Syringes Market, Global, Revenue, 2005–2012
7.6 Insulin Syringes Market, Global, Revenue, 2012–2019
7.7 Traditional Insulin Pump Accessories Market, Global, Revenue, 2005–2012
7.8 Traditional Insulin Pump Accessories Market, Global, Revenue, 2012–2019

8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts

8.1 Insulin Delivery Devices Market: Cross-country Analysis
8.2 Historic and Forecast Revenue and Volume, by Country
8.2.1 Insulin Delivery Devices Market, US, Revenue and Volume, 2005–2019
8.2.2 Insulin Delivery Devices Market, Japan, Revenue and Volume, 2005–2019
8.2.3 Insulin Delivery Devices Market, Germany, Revenue and Volume, 2005–2019
8.2.4 Insulin Delivery Devices Market, France, Revenue, 2005–2012
8.2.5 Insulin Delivery Devices Market, UK, Revenue and Volume, 2005–2019
8.2.6 Insulin Delivery Devices Market, Spain, Revenue, Volume, 2005–2019
8.2.7 Insulin Delivery Devices Market, Italy, Revenue, Volume, 2005–2019
8.2.8 Insulin Delivery Devices Market, Canada, Revenue, Volume, 2005–2019
8.2.9 Insulin Delivery Devices Market, China, Revenue, Volume, 2005–2019
8.2.10 Insulin Delivery Devices Market, Australia, Revenue, Volume, 2005–2019
8.2.11 Insulin Delivery Devices Market, India, Revenue, 2005–2012
8.2.12 Insulin Delivery Devices Market, Brazil, Revenue, 2005–2019

9 Global Insulin Delivery Devices Market: Reimbursement System

9.1 US
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 Spain
9.2.5 UK
9.2.6 Denmark
9.2.7 Norway
9.2.8 Sweden
9.2.9 Belgium
9.2.10 Netherlands
9.2.11 Luxembourg
9.3 Asia-Pacific

10 Global Insulin Delivery Devices Market: Competitive Landscape

10.1 Comparison of Leading Insulin Pumps by Size and Color Options, 2014
10.2 Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014
10.3 Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014
10.4 Novo Nordisk (Subsidiary of Novo A/S)
10.4.1 Business Overview
10.4.2 Marketed Products
10.5 Sanofi 89
10.5.1 Business Overview
10.5.2 Marketed Products
10.6 Eli Lilly 89
10.6.1 Business Overview
10.6.2 Marketed Products
10.7 Medtronic 90
10.7.1 Business Overview
10.7.2 Marketed Products
10.8 Becton, Dickinson and Company
10.8.1 Business Overview
10.8.2 Marketed Products
10.9 Animas 91
10.9.1 Business Overview
10.9.2 Marketed Products
10.10 F. Hoffmann-La Roche
10.10.1 Business Overview
10.10.2 Marketed Products
10.11 Insulet 92
10.11.1 Business Overview
10.11.2 Marketed Products
10.12 Asante Solutions 92
10.12.1 Business Overview
10.13 Abbott Laboratories
10.13.1 Business Overview
10.13.2 Marketed Products
10.14 Ypsomed
10.14.1 Business Overview
10.14.2 Marketed Products
10.15 Owen Mumford
10.15.1 Business Overview
10.15.2 Marketed Products
10.16 Bioject Medical Technologies
10.16.1 Business Overview
10.16.2 Marketed Products
10.17 Injex - Equidyne Systems
10.17.1 Business Overview
10.17.2 Marketed Products
10.18 Antares Pharma
10.18.1 Business Overview
10.18.2 Marketed Products
10.19 Tandem Diabetes Care
10.19.1 Business Overview
10.19.2 Marketed Products
10.20 Tonghua Dongbao Pharmaceutical
10.20.1 Business Overview
10.20.2 Marketed Products
10.21 Shanghai Fosun Pharmaceutical
10.21.1 Business Overview
10.21.2 Marketed Products

11 Global Insulin Delivery Devices Market: Product Pipeline Analysis

11.1 Insulin Delivery Devices Market: List of Pipeline Products
11.1.1 Insulin Pumps, List of Pipeline Products
11.1.2 Insulin Pens, List of Pipeline Products
11.2 Insulin Delivery Devices Market: Profiles of Key Pipeline Products
11.2.1 5th Generation CGM Sensor with t:slim Insulin Delivery System
11.2.2 Accu-Chek Insight
11.2.3 Angel Touch
11.2.4 Animas Vibe Insulin Pump and CGM System
11.2.5 Bolus Patch
11.2.6 Cellnovo Wireless Insulin Pump System
11.2.7 Freehand Patch Pump
11.2.8 Insulin Pump
11.2.9 InsuPatch Device
11.2.10 Integrated CGM with Next Gen OmniPod System PDM
11.2.11 Jewel Pump
11.2.12 La Fenice E
11.2.13 La Fenice V
11.2.14 Lanzi
11.2.15 Mini Pump
11.2.16 MiniMed 640G
11.2.17 MinIn
11.2.18 OmniPod Insulin Pump – New Version
11.2.19 Onetouch Ping Verio Insulin Pump with Meter Remote
11.2.20 OneTouch with Next Gen Omnipod
11.2.21 Patch Pump-1
11.2.22 Patch Pump-2
11.2.23 Patch Pump-3
11.2.24 Spring Insulin Pump
11.2.25 Spring Zone Hybrid Patch Pump
11.2.26 U-Strip Insulin Patch
11.2.27 Exenatide Once Weekly Pen Device
11.2.28 Fix-Flex Device
11.2.29 G-Pen
11.2.30 G-Pen Mini
11.2.31 Insulin Guard Self-Injector Safety Needle
11.2.32 JuniorSTAR
11.2.33 La Fenice Pen
11.2.34 Levemir FlexTouch
11.2.35 Next Generation Pen Needle II
11.2.36 NovoLog FlexTouch

12 Global Insulin Delivery Devices Market: Consolidation Landscape

12.1 Deals Summary (2004–2013)
12.2 Key Deals (2009–2013)
12.2.1 LifeScan Acquires Calibra Medical
12.2.2 Roche Holding Acquires Medingo from Elron Electronic Industries, 2010
12.2.3 Insulet Enters into Co-Development Agreement with Eli Lilly, 2013
12.2.4 Tandem Diabetes Enters into Co-Development Agreement with Juvenile Diabetes Research Foundation for Dual-Chamber Infusion Pump, 2013
12.2.5 Juvenile Diabetes Research Foundation Extends Co-Development Agreement with Becton, Dickinson, 2012
12.2.6 Bioton and SciGen Amend Distribution Agreement with Bayer HealthCare, 2012
12.2.7 Insulet Expands Distribution Agreement with Ypsomed Holding, 2012

13 Appendix

13.1 Definitions
13.1.1 Insulin Delivery
13.2 Abbreviations
13.3 Bibliography
13.4 Research Methodology
13.4.1 Secondary Research
13.4.2 Primary Research
13.4.3 Models
13.4.4 Forecasts
13.4.5 Expert Panel
13.5 Contact Us
13.6 Disclaimer

1.1 List of Tables

Table 1: Insulin Delivery Devices Market, Global, Diabetes National Prevalence (%) and Patient Population (million), 2013
Table 2: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005–2012
Table 3: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012–2019
Table 4: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012
Table 5: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29–79 Years), 2013–2035
Table 6: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20–79 Years) and Diabetes Population, 2013
Table 7: Insulin Pens Market, Global, Revenue ($bn), 2005–2012
Table 8: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012–2019
Table 9: Insulin Pumps Market, Global, Revenue ($m), 2005–2012
Table 10: Insulin Pumps Market, Global, Revenue ($m), 2012–2019
Table 11: Insulin Syringes Market, Global, Revenue ($m), 2005–2012
Table 12: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012–2019
Table 13: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005–2012
Table 14: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012–2019
Table 15: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005–2019
Table 16: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005–2012
Table 17: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2012–2019
Table 18: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume (‘000), 2005–2012
Table 19: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume (‘000), 2012–2019
Table 20: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume (‘000), 2005–2012
Table 21: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume (‘000), 2012–2019
Table 22: Insulin Delivery Devices Market, France, Revenue ($m), Volume (‘000), 2005–2012
Table 23: Insulin Delivery Devices Market, France, Revenue ($m), Volume (‘000), 2012–2019
Table 24: Insulin Delivery Devices Market, UK, Revenue ($m), Volume (‘000), 2005–2012 61
Table 25: Insulin Delivery Devices Market, UK, Revenue ($m), Volume (‘000), 2012–2019 61
Table 26: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume (‘000), 2005–2012
Table 27: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume (‘000), 2012–2019
Table 28: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume (‘000), 2005–2012
Table 29: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume (‘000), 2012–2019
Table 30: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume (‘000), 2005–2012
Table 31: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume (‘000), 2012–2019
Table 32: Insulin Delivery Devices Market, China, Revenue ($m), Volume (‘000), 2005–2012
Table 33: Insulin Delivery Devices Market, China, Revenue ($m), Volume (‘000), 2012–2019
Table 34: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume (‘000), 2005–2012
Table 35: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume (‘000), 2012–2019
Table 36: Insulin Delivery Devices Market, India, Revenue ($m), Volume (‘000), 2005–2012
Table 37: Insulin Delivery Devices Market, India, Revenue ($m), Volume (‘000), 2012–2019
Table 38: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume (‘000), 2005–2012
Table 39: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume (‘000), 2012–2019
Table 40: Novo Nordisk, Key Marketed Products, 2013
Table 41: Sanofi, Key Marketed Products, 2013
Table 42: Eli Lilly, Key Marketed Products, 2013
Table 43: Abbott Laboratories, Key Marketed Products, 2013
Table 44: Becton, Dickinson and Company, Key Marketed Products, 2013
Table 45: Animas, Key Marketed Products, 2013
Table 46: F. Hoffmann-La Roche, Key Marketed Products, 2013
Table 47: Insulet, Key Marketed Products, 2013
Table 48: Asante Solutions, Key Marketed Products, 2013
Table 49: Abbott Laboratories, Key Marketed Products, 2013
Table 50: Ypsomed Holding AG, Key Marketed Products, 2013
Table 51: Owen Mumford, Key Marketed Products, 2014
Table 52: Bioject Medical Technologies, Key Marketed Products, 2014
Table 53: INJEX - Equidyne Systems, Key Marketed Products, 2014
Table 54: Antares Pharma, Key Marketed Products, 2014
Table 55: Tandem Diabetes Care, Key Marketed Products, 2014
Table 56: Tonghua Dongbao Pharmaceutical, Key Marketed Products, 2014
Table 57: Shanghai Fosun Pharmaceutical, Key Marketed Products, 2014
Table 58: Insulin Pumps Market, Global, List of Pipeline Products, 2014
Table 59: Insulin Pens Market, Global, List of Pipeline Products, 2014
Table 60: 5th Generation CGM Sensor With t:slim Insulin Delivery System, Product Status, 2014
Table 61: Accu-Chek Insight, Product Status, 2014
Table 62: Angel Touch, Product Status, 2014
Table 63: Animas Vibe Insulin Pump and CGM System, Product Status, 2014
Table 64: Bolus Patch, Product Status, 2014
Table 65: Cellnovo Wireless Insulin Pump System, Product Status, 2014
Table 66: Freehand Patch Pump, Product Status, 2014
Table 67: Insulin Pump, Product Status, 2014
Table 68: InsuPatch Device, Product Status, 2014
Table 69: Integrated CGM With Next Gen OmniPod System PDM, Product Status, 2014
Table 70: Jewel Pump, Product Status, 2014
Table 71: La Fenice E, Product Status, 2014
Table 72: La Fenice V, Product Status, 2014
Table 73: Lanzi, Product Status, 2014
Table 74: Mini Pump, Product Status, 2014
Table 75: MiniMed 640G, Product Status, 2014
Table 76: MinIn, Product Status, 2014
Table 77: OmniPod Insulin Pump – New Version, Product Status, 2014
Table 78: Onetouch Ping Verio Insulin Pump with Meter Remote, Product Status, 2014
Table 79: OneTouch with Next Gen Omnipod, Product Status, 2014
Table 80: Patch Pump-1, Product Status, 2014
Table 81: Patch Pump-2, Product Status, 2014
Table 82: Patch Pump-3, Product Status, 2014
Table 83: Spring Insulin Pump, Product Status, 2014
Table 84: Spring Zone Hybrid Patch Pump, Product Status, 2014
Table 85: U-Strip Insulin Patch, Product Status, 2014
Table 86: Exenatide Once Weekly Pen Device, Product Status, 2014
Table 87: Fix-Flex Device, Product Status, 2014
Table 88: G-Pen, Product Status, 2014
Table 89: G-Pen Mini, Product Status, 2014
Table 90: Insulin Guard Self-Injector Safety Needle, Product Status, 2014
Table 91: JuniorSTAR, Product Status, 2014
Table 92: La Fenice Pen, Product Status, 2014
Table 93: Levemir FlexTouch, Product Status, 2014
Table 94: Next Generation Pen Needle II, Product Status, 2014
Table 95: NovoLog FlexTouch, Product Status, 2014

1.2 List of Figures

Figure 1: Insulin Delivery Devices Market, Insulin Pump Timeline, 1963–2011
Figure 2: Insulin Delivery Devices Market, Device Overview
Figure 3: Insulin Delivery Devices Market, Comparison of Insulin Therapy
Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005–2012
Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012–2019
Figure 6: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012
Figure 7: Insulin Delivery Devices Market, Market Trends
Figure 8: Insulin Delivery Devices Market, Ongoing/Completed Studies on Artificial Pancreas
Figure 9: Insulin Delivery Devices Market, Leading Integrated CGM-Insulin Pump Brands, 2013
Figure 10: Insulin Delivery Devices Market, Market Dynamics
Figure 11: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29–79 Years), 2013–2035
Figure 12: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20–79 Years) and Diabetes Population, 2013
Figure 13: Insulin Delivery Devices Market, Clinical Studies Indicating Safety and Efficacy of Insulin Pumps
Figure 14: Insulin Delivery Devices Market, Annual Cost of Insulin Pumps and Supplies and Annual Cost of Treatment for Serious Complications in Alberta, Canada, 2012 and 2032
Figure 15: Insulin Delivery Devices Market, Clinical Studies Indicating Advantages of Insulin Pens Over Syringes
Figure 16: Insulin Delivery Devices Market, Patient Compliance Analysis for Insulin Pens and Insulin Syringes
Figure 17: Insulin Pens Market, Global, Revenue ($bn), 2005–2012
Figure 18: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012–2019
Figure 19: Insulin Pumps Market, Global, Revenue ($m), 2005–2012
Figure 20: Insulin Pumps Market, Global, Revenue Forecast ($m), 2012–2019
Figure 21: Insulin Syringes Market, Global, Revenue ($m), 2005–2012
Figure 22: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012–2019
Figure 23: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005–2012
Figure 24: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012–2019
Figure 25: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005–2019
Figure 26: Insulin Delivery Devices Market, US, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 27: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005–2019
Figure 28: Insulin Delivery Devices Market, Japan, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 29: Insulin Delivery Devices Market, Japan, Revenue and Volume (000s), 2005–2019
Figure 30: Insulin Delivery Devices Market, Germany, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 31: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume (‘000), 2005–2019
Figure 32: Insulin Delivery Devices Market, France, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 33: Insulin Delivery Devices Market, France, Revenue ($m), Volume (‘000), 2005–2019
Figure 34: Insulin Delivery Devices Market, UK, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 35: Insulin Delivery Devices Market, UK, Revenue ($m), Volume (‘000), 2005–2019
Figure 36: Insulin Delivery Devices Market, Spain, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 37: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume (‘000), 2005–2019
Figure 38: Insulin Delivery Devices Market, Italy, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 39: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume (‘000), 2005–2019
Figure 40: Insulin Delivery Devices Market, Canada, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 41: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume (‘000), 2005–2019
Figure 42: Insulin Delivery Devices Market, China, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 43: Insulin Delivery Devices Market, China, Revenue ($m), Volume (‘000), 2005–2019
Figure 44: Insulin Delivery Devices Market, Australia, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 45: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume (‘000), 2005–2019
Figure 46: Insulin Delivery Devices Market, India, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 47: Insulin Delivery Devices Market, India, Revenue ($m), Volume (‘0000), 2005–2019
Figure 48: Insulin Delivery Devices Market, Brazil, Cross-segment Analysis, CAGR (%), 2005–2019
Figure 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume (‘000), 2005–2019
Figure 50: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Size and Color Options, 2014
Figure 51: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014
Figure 52: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014
Figure 53: Global Insulin Delivery Devices Market, Pipeline Products Summary, 2013
Figure 54: Global Insulin Delivery Devices Market, Deals Summary, 2013
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Antares Pharma
  • Eli Lilly
  • Injex - Equidyne Systems
  • Medtronic
  • Sanofi
  • MORE
The global insulin delivery devices market was valued at $8.8 billion in 2012 and is forecast to reach $13.8 billion by 2019, at a CAGR of 7%. Growth in developed economies such as the US and Europe is attributed to an increasing preference for insulin pumps and the uptake of technical advances such as artificial pancreas devices. Supply-side initiatives aim to develop artificial pancreas devices that closely mimic the pancreas by using rapid-acting insulin and multiple hormone-secreting devices for the effective control of blood glucose. The growth in developing economies is attributed to the high prevalence of diabetes and low penetration of insulin delivery devices in these countries.

Collaborations among companies and research foundations such as the Juvenile Diabetes Research Foundation (JDRF) help foster innovation in the diabetes care devices market. Many of these collaborations aim to develop artificial pancreas devices that can effectively replace the pancreas, ensuring the effective management of diabetes.

Emerging economies such as India and China are expected to grow at the fastest pace during the 2012–2019 forecast period. While developed economies will witness increasing uptake of technically advanced devices, emerging economies will continue to see increasing uptake for conventional insulin delivery devices such as insulin pens, due to their lower cost."
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Animas
- Antares Pharma
- Asante Solutions
- Becton, Dickinson and Company
- Bioject Medical Technologies
- Eli Lilly
- F. Hoffmann-La Roche
- Injex - Equidyne Systems
- Insulet
- Medtronic
- Novo Nordisk (Subsidiary of Novo A/S)
- Owen Mumford
- Sanofi
- Shanghai Fosun Pharmaceutical
- Tandem Diabetes Care
- Tonghua Dongbao Pharmaceutical
- Ypsomed
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/2786167
Adroll
adroll